Search Results - "Kisselev, Alexei F."

Refine Results
  1. 1

    Site-Specific Proteasome Inhibitors by Kisselev, Alexei F

    Published in Biomolecules (Basel, Switzerland) (31-12-2021)
    “…Proteasome is a multi-subunit protein degradation machine, which plays a key role in the maintenance of protein homeostasis and, through degradation of…”
    Get full text
    Journal Article
  2. 2

    Early recovery of proteasome activity in cells pulse-treated with proteasome inhibitors is independent of DDI2 by Ibtisam, Ibtisam, Kisselev, Alexei F

    Published in eLife (15-04-2024)
    “…Rapid recovery of proteasome activity may contribute to intrinsic and acquired resistance to FDA-approved proteasome inhibitors. Previous studies have…”
    Get full text
    Journal Article
  3. 3

    NEIL3-mediated proteasomal degradation facilitates the repair of cisplatin-induced DNA damage in human cells by Aliyaskarova, Umit, Baiken, Yeldar, Renaud, Flore, Couve, Sophie, Kisselev, Alexei F., Saparbaev, Murat, Groisman, Regina

    Published in Scientific reports (30-03-2023)
    “…Anti-neoplastic effect of DNA cross-linking agents such as cisplatin, mitomycin C, and psoralen is attributed to their ability to induce DNA interstrand…”
    Get full text
    Journal Article
  4. 4

    A clinically relevant pulse treatment generates a bortezomib-resistant myeloma cell line that lacks proteasome mutations and is sensitive to Bcl-2 inhibitor venetoclax by Downey-Kopyscinski, Sondra L., Srinivasa, Sriraja, Kisselev, Alexei F.

    Published in Scientific reports (27-07-2022)
    “…Proteasome inhibitors bortezomib and carfilzomib are the backbones of treatments of multiple myeloma, which remains incurable despite many recent advances…”
    Get full text
    Journal Article
  5. 5

    Importance of the Different Proteolytic Sites of the Proteasome and the Efficacy of Inhibitors Varies with the Protein Substrate by Kisselev, Alexei F., Callard, Alice, Goldberg, Alfred L.

    Published in The Journal of biological chemistry (31-03-2006)
    “…The relative importance of the different proteolytic sites in mammalian proteasomes in protein degradation has not been studied systematically. Nevertheless,…”
    Get full text
    Journal Article
  6. 6

    A Novel Bullet Hits the Proteasome by Kisselev, Alexei F.

    Published in Cancer cell (09-12-2013)
    “…An elegant paper by Anchoori and colleagues in this issue of Cancer Cell describes an irreversible inhibitor of Rpn13, one of the ubiquitin receptors on the…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Activity of immunoproteasome inhibitor ONX-0914 in acute lymphoblastic leukemia expressing MLL–AF4 fusion protein by Jenkins, Tyler W., Downey-Kopyscinski, Sondra L., Fields, Jennifer L., Rahme, Gilbert J., Colley, William C., Israel, Mark A., Maksimenko, Andrey V., Fiering, Steven N., Kisselev, Alexei F.

    Published in Scientific reports (25-05-2021)
    “…Proteasome inhibitors bortezomib and carfilzomib are approved for the treatment of multiple myeloma and mantle cell lymphoma and have demonstrated clinical…”
    Get full text
    Journal Article
  9. 9

    Multiple BH3 Mimetics Antagonize Antiapoptotic MCL1 Protein by Inducing the Endoplasmic Reticulum Stress Response and Up-regulating BH3-only Protein NOXA by Albershardt, Tina C., Salerni, Bethany L., Soderquist, Ryan S., Bates, Darcy J.P., Pletnev, Alexandre A., Kisselev, Alexei F., Eastman, Alan

    Published in The Journal of biological chemistry (15-07-2011)
    “…BH3 mimetics are small molecules designed or discovered to mimic the binding of BH3-only proteins to the hydrophobic groove of antiapoptotic BCL2 proteins. The…”
    Get full text
    Journal Article
  10. 10

    The Ubiquitin Ligase Activity in the DDB2 and CSA Complexes Is Differentially Regulated by the COP9 Signalosome in Response to DNA Damage by Groisman, Regina, Polanowska, Jolanta, Kuraoka, Isao, Sawada, Jun-ichi, Saijo, Masafumi, Drapkin, Ronny, Kisselev, Alexei F., Tanaka, Kiyoji, Nakatani, Yoshihiro

    Published in Cell (02-05-2003)
    “…Nucleotide excision repair (NER) is a major cellular defense against the carcinogenic effects of ultraviolet light from the sun. Mutational inactivation of NER…”
    Get full text
    Journal Article
  11. 11

    CSA-dependent degradation of CSB by the ubiquitin-proteasome pathway establishes a link between complementation factors of the Cockayne syndrome by Groisman, Regina, Kuraoka, Isao, Chevallier, Odile, Gaye, Nogaye, Magnaldo, Thierry, Tanaka, Kiyoji, Kisselev, Alexei F, Harel-Bellan, Annick, Nakatani, Yoshihiro

    Published in Genes & development (01-06-2006)
    “…Mutations in the CSA or CSB complementation genes cause the Cockayne syndrome, a severe genetic disorder that results in patients' death in early adulthood…”
    Get full text
    Journal Article
  12. 12

    Molecular basis of differential sensitivity of myeloma cells to clinically relevant bolus treatment with bortezomib by Shabaneh, Tamer B, Downey, Sondra L, Goddard, Ayrton L, Screen, Michael, Lucas, Marcella M, Eastman, Alan, Kisselev, Alexei F

    Published in PloS one (27-02-2013)
    “…The proteasome inhibitor bortezomib (Velcade) is prescribed for the treatment of multiple myeloma. Clinically achievable concentrations of bortezomib cause…”
    Get full text
    Journal Article
  13. 13
  14. 14

    DNA-Histone Cross-Links: Formation and Repair by Pachva, Manideep C, Kisselev, Alexei F, Matkarimov, Bakhyt T, Saparbaev, Murat, Groisman, Regina

    “…The nucleosome is a stretch of DNA wrapped around a histone octamer. Electrostatic interactions and hydrogen bonds between histones and DNA are vital for the…”
    Get full text
    Journal Article
  15. 15

    Subunit specific inhibitors of proteasomes and their potential for immunomodulation by Kisselev, Alexei F, Groettrup, Marcus

    Published in Current opinion in chemical biology (01-12-2014)
    “…•Structure–function relationship of subunit selective proteasome inhibitors.•Development and characterization of new inhibitors of the…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Proteasome Active Sites Allosterically Regulate Each Other, Suggesting a Cyclical Bite-Chew Mechanism for Protein Breakdown by Kisselev, Alexei F, Akopian, Tatos N, Castillo, Vanesa, Goldberg, Alfred L

    Published in Molecular cell (01-09-1999)
    “…In eukaryotes, the 20S proteasome contains two chymotrypsin-like, two trypsin-like, and two active sites shown here to have caspase-like specificity. We report…”
    Get full text
    Journal Article
  18. 18

    Proteasome Inhibitors: An Expanding Army Attacking a Unique Target by Kisselev, Alexei F., van der Linden, Wouter A., Overkleeft, Herman S.

    Published in Chemistry & biology (27-01-2012)
    “…Proteasomes are large, multisubunit proteolytic complexes presenting multiple targets for therapeutic intervention. The 26S proteasome consists of a 20S…”
    Get full text
    Journal Article
  19. 19

    Incorporation of Fluorinated Phenylalanine Generates Highly Specific Inhibitor of Proteasome’s Chymotrypsin-like Sites by Geurink, Paul P, Liu, Nora, Spaans, Michiel P, Downey, Sondra L, van den Nieuwendijk, Adrianus M. C. H, van der Marel, Gijsbert A, Kisselev, Alexei F, Florea, Bogdan I, Overkleeft, Herman S

    Published in Journal of medicinal chemistry (11-03-2010)
    “…Proteasomal processing is conducted by three individual catalytic subunits, namely β1, β2, and β5. Subunit-specific inhibitors are useful tools in dissecting…”
    Get full text
    Journal Article
  20. 20

    The fellowship of the ring by Tevosian, Sergei G., Kisselev, Alexei F.

    Published in Cancer biology & therapy (01-01-2011)
    “…Commentary to: Proteasome inhibitory activity of thiazole antibiotics Bulbul Pandit, Uppoor G. Bhat and Andrei Gartel…”
    Get full text
    Journal Article